BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 9065059)

  • 21. [Etiology and pathogenesis of type I diabetes].
    Ziegler AG
    Z Gesamte Inn Med; 1993 Mar; 48(3):100-7. PubMed ID: 8475631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The pathogenesis of type 1 diabetes mellitus].
    Schönle EJ
    Ther Umsch; 1990 Jan; 47(1):15-21. PubMed ID: 2408178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes.
    Naserke HE; Ziegler AG; Lampasona V; Bonifacio E
    J Immunol; 1998 Dec; 161(12):6963-9. PubMed ID: 9862731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
    Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC
    J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Predicting the development of diabetes mellitus type 1].
    Jaskóła K; Bernaś M; Luźniak P; Szczeklik Z; Tatoń J
    Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):40-2. PubMed ID: 1409041
    [No Abstract]   [Full Text] [Related]  

  • 26. Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes.
    Williams AJ; Bingley PJ; Moore WP; Gale EA;
    Diabetologia; 2002 Feb; 45(2):217-23. PubMed ID: 11935153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoimmune markers in young Malaysian patients with type 1 diabetes mellitus.
    Nazaimoon WM; Azmi KN; Rasat R; Ismail IS; Singaraveloo M; Mohamad WB; Letchuman R; Sheriff IH; Faridah I; Khalid BA
    Med J Malaysia; 2000 Sep; 55(3):318-23. PubMed ID: 11200711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunologic and genetic markers in insulin-dependent diabetes mellitus (type 1) in an Argentine population.
    Krochik AG; Mazza CS; Valdez SN; Stumpo RR; Papouchado ML; Iacono RF; Cardoso Landaburu AC; Sica MP; Ozuna B; Poskus E
    Medicina (B Aires); 2001; 61(3):279-83. PubMed ID: 11474874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Islet autoantibody assays in type I diabetes: superiority of passage from use of ICA to traditional tests].
    Lazar D; Weintrob N; Abramov N; Assa S; Bloch K; Ofan R; Ben-Zaken H; Vardi P
    Harefuah; 1998 May; 134(9):678-81, 750. PubMed ID: 10909610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transient insulin autoantibody expression independent of development of diabetes: comparison of NOD and NOR strains.
    Abiru N; Yu L; Miao D; Maniatis AK; Liu E; Moriyama H; Eisenbarth GS
    J Autoimmun; 2001 Aug; 17(1):1-6. PubMed ID: 11488632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progression of autoimmune diabetes: slowly progressive insulin-dependent diabetes mellitus or latent autoimmune diabetes of adult.
    Beyan H; Ola T; David R; Leslie G
    Ann N Y Acad Sci; 2006 Oct; 1079():81-9. PubMed ID: 17130535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An islet cell antibody negative form of insulin-dependent diabetes mellitus (IDD) associated with HLA antigens A9 and Bw16.
    Mustonen A; Ilonen J; Akerblom HK; Tiilikainen A
    Clin Exp Immunol; 1982 Apr; 48(1):213-7. PubMed ID: 7044630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin autoantibodies in mouse models of insulin-dependent diabetes.
    Maruyama T; Takei I; Asaba Y; Yanagawa T; Takahashi T; Itoh H; Suzuki Y; Kataoka K; Saruta T; Ishii T
    Diabetes Res; 1989 Jun; 11(2):61-5. PubMed ID: 2620486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoantibodies to pancreatic islet cells and insulin in IDDM families: the GAW5 data.
    Maclaren NK; Riley WJ; McCulloch DK; Palmer JP
    Genet Epidemiol; 1989; 6(1):39-41. PubMed ID: 2659429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C. L. Oakley lecture (1987). The pathogenesis of beta cell destruction in type I (insulin-dependent) diabetes mellitus.
    Foulis AK
    J Pathol; 1987 Jul; 152(3):141-8. PubMed ID: 3309229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Islet autoimmunity in children with Down's syndrome.
    Gillespie KM; Dix RJ; Williams AJ; Newton R; Robinson ZF; Bingley PJ; Gale EA; Shield JP
    Diabetes; 2006 Nov; 55(11):3185-8. PubMed ID: 17065360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developments in the prediction of type 1 diabetes mellitus, with special reference to insulin autoantibodies.
    Franke B; Galloway TS; Wilkin TJ
    Diabetes Metab Res Rev; 2005; 21(5):395-415. PubMed ID: 15895384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prevalence of type 1 diabetes-specific autoantibodies and of certain HLA patterns in celiac disease].
    Schilling I; Conrad K; Füssel M; Henker J
    Dtsch Med Wochenschr; 2003 Jan; 128(5):185-9. PubMed ID: 12557109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Why diabetes incidence increases--a unifying theory.
    Ludvigsson J
    Ann N Y Acad Sci; 2006 Oct; 1079():374-82. PubMed ID: 17130582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunopathological and genetic features in slowly progressive insulin-dependent diabetes mellitus and latent autoimmune diabetes in adults.
    Kobayashi T; Tanaka S; Harii N; Aida K; Shimura H; Ohmori M; Kanesige M; Shimada A; Maruyama T
    Ann N Y Acad Sci; 2006 Oct; 1079():60-6. PubMed ID: 17130533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.